1-9 of 9
Authors: Juan Berenguer
Journal Article
Blood microbiome is associated with changes in portal hypertension after successful direct-acting antiviral therapy in patients with HCV-related cirrhosis
Journal of Antimicrobial Chemotherapy, Volume 77, Issue 3, March 2022, Pages 719–726, https://doi.org/10.1093/jac/dkab444
Published: 09 December 2021
Journal Article
Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen
Journal of Antimicrobial Chemotherapy, Volume 71, Issue 5, May 2016, Pages 1352–1360, https://doi.org/10.1093/jac/dkv465
Published: 28 January 2016
Journal Article
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART
Journal of Antimicrobial Chemotherapy, Volume 71, Issue 4, April 2016, Pages 1056–1062, https://doi.org/10.1093/jac/dkv427
Published: 24 December 2015
Journal Article
European mitochondrial haplogroups are associated with CD4+ T cell recovery in HIV-infected patients on combination antiretroviral therapy Get access
Journal of Antimicrobial Chemotherapy, Volume 68, Issue 10, October 2013, Pages 2349–2357, https://doi.org/10.1093/jac/dkt206
Published: 07 June 2013
Journal Article
Plasma IL-6 and IL-9 predict the failure of interferon-α plus ribavirin therapy in HIV/HCV-coinfected patients Get access
Journal of Antimicrobial Chemotherapy, Volume 67, Issue 5, May 2012, Pages 1238–1245, https://doi.org/10.1093/jac/dkr595
Published: 31 January 2012
Journal Article
Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus Get access
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 12, December 2011, Pages 2843–2849, https://doi.org/10.1093/jac/dkr362
Published: 29 September 2011
Journal Article
Sustained virological response to interferon-α plus ribavirin decreases inflammation and endothelial dysfunction markers in HIV/HCV co-infected patients Get access
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 3, March 2011, Pages 645–649, https://doi.org/10.1093/jac/dkq518
Published: 14 January 2011
Journal Article
Association between plasma levels of eotaxin (CCL-11) and treatment response to interferon-α and ribavirin in HIV/HCV co-infected patients Get access
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 2, February 2010, Pages 303–306, https://doi.org/10.1093/jac/dkp454
Published: 16 December 2009
Journal Article
Lipid disorders in antiretroviral-naive patients treated with lopinavir/ritonavir-based HAART: frequency, characterization and risk factors Get access
Journal of Antimicrobial Chemotherapy, Volume 55, Issue 5, May 2005, Pages 800–804, https://doi.org/10.1093/jac/dki063
Published: 01 May 2005
